KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Notes Payables (2020 - 2024)

Labcorp Holdings (LH) has disclosed Notes Payables for 8 consecutive years, with $1.4 billion as the latest value for Q3 2024.

  • Quarterly Notes Payables rose 41.26% to $1.4 billion in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Sep 2024, up 41.26% year-over-year, with the annual reading at $999.8 million for FY2023, 231.83% up from the prior year.
  • Notes Payables hit $1.4 billion in Q3 2024 for Labcorp Holdings, down from $2.0 billion in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $2.0 billion in Q1 2024 to a low of $1.5 million in Q4 2021.
  • Historically, Notes Payables has averaged $577.7 million across 5 years, with a median of $301.4 million in 2023.
  • Biggest five-year swings in Notes Payables: plummeted 99.68% in 2022 and later skyrocketed 58194.12% in 2023.
  • Year by year, Notes Payables stood at $376.7 million in 2020, then plummeted by 99.6% to $1.5 million in 2021, then skyrocketed by 19986.67% to $301.3 million in 2022, then soared by 231.83% to $999.8 million in 2023, then skyrocketed by 40.02% to $1.4 billion in 2024.
  • Business Quant data shows Notes Payables for LH at $1.4 billion in Q3 2024, $2.0 billion in Q2 2024, and $2.0 billion in Q1 2024.